Deerfield Management Company, L.P. (Series C) Bio Rad Laboratories, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 226,070 shares of BIO stock, worth $57.2 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
226,070
Previous 151,644
49.08%
Holding current value
$57.2 Million
Previous $49.8 Million
10.53%
% of portfolio
1.39%
Previous 1.23%
Shares
7 transactions
Others Institutions Holding BIO
# of Institutions
449Shares Held
18.7MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$484 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$397 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$393 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$231 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$222 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.24B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...